Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 2014. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes
The filing details a specific transaction on January 10, 2014, involving Mr. P C Thomson and Mrs. K Thomson (Connected Persons). They acquired Ordinary Shares through the Company's ShareReward Plan at a price of 1606.55 pence per share. The transaction included:
- Acquisition of 1 Ordinary Share under the personal contribution element.
- Acquisition of 1 Ordinary Share under the matching element (Company contribution).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the share acquisition transaction in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
Key Facts for Investor Verification
- Transaction Date: January 10, 2014.
- Share Price: 1606.55 pence per Ordinary Share.
- Participants: Mr. P C Thomson and Mrs. K Thomson.
- Plan Details: Shares acquired via the ShareReward Plan (1 personal, 1 company match).
- Notification Date: January 13, 2014.